Synovial tissue analysis in rheumatoid arthritis

Bailliere's Best Practice and Research in Clinical Rheumatology

Volumn 13, Issue 4, 1999, Pages 645-659

  Bresnihan, Barry ^a   Tak, Paul P ^b  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Inflammation; Rheumatoid arthritis; Synovial tissue; Synovitis; Treatment

Indexed keywords

ARTHROSCOPY; DISEASE ACTIVITY; HUMAN; IMMUNOHISTOLOGY; NEEDLE BIOPSY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RHEUMATOID ARTHRITIS; SYNOVIUM;

EID: 0033394852     PISSN: 15216942     EISSN: None     Source Type: Journal    
DOI: 10.1053/berh.1999.0051     Document Type: Article

References (80)

1. Schumacher H R. Synovial fluid analysis and synovial biopsy. Kelly W N, Harris E D, Ruddy S, Sledge C B. Textbook of Rheumatology. 1993;562-578 WB Saunders Company, Philadelphia.
2. Tak P P, Lindblad S, Klareskog L, Breedveld F C. Synovial biopsies for analysis of the synovial membrane: new perspectives. Newsletter of European Rheumatology Research. 2:1994;27-29.
3. Kalunian K C, Moreland L W, Ike R W. Arthroscopy. Koopman W J. Arthritis and allied conditions. 1996;103-114 Williams & Wilkins, Philadelphia.
4. Soden M, Rooney M, Cullen A. Immunohistological features in the synovium obtained from clinically uninvolved knee joints of patients with rheumatoid arthritis. British Journal of Rheumatology. 28:1989;287-292.
5. Arayssi T K, Schumacher H R. Evaluation of a modified needle for small joint biopsies. Journal of Rheumatology. 25:1998;876-878.
6. Arnold W J. Office-based arthroscopy. Bulletin of Rheumatic Diseases. 41:1992;3-6.
7. Chang R W, Sharma L. Why a rheumatologist should be interested in arthroscopy. Arthritis and Rheumatism. 37:1994;1573-1576.
8. Reece R J, Emery P. Needle arthroscopy. British Journal of Rheumatology. 34:1995;1102-1104.
9. Reece R J, Canete J D, Emery P, Veale D J. Small joint arthroscopy: a safe, efficacious and well tolerated procedure in early inflammatory arthritis. Arthritis and Rheumatism. 40:1997;S246.
10. Yanni G, Whelan A, Feighery C, Bresnihan B. Analysis of cell populations in rheumatoid arthritis synovial tissues. Seminars in Arthritis and Rheumatism. 21:1992;393-399.
11. Tak P P, Smeets T JM, Daha M R. Analysis of the synovial cellular infiltrate in early rheumatoid synovial tissue in relation to local disease activity. Arthritis and Rheumatism. 40:1997;217-225.
12. De Paulis A, Marino I, Ciccarelli A. Human synovial mast cells. 1. Ultrastructural in situ and in vitro immunologic characterisation. Arthritis and Rheumatism. 39:1996;1222-1233.
13. Tak P P, Kummer J A, Hack C E. Granzyme positive cytotoxic cells are specifically increased in early rheumatoid synovial tissue. Arthritis and Rheumatism. 37:1994;1735-1743.
14. Smeets T JM, Dolhain R JEM, Breedveld F C, Tak P P. Analysis of the cellular infiltrates and expression of cytokines in synovial tissue from patients with rheumatoid arthritis and reactive arthritis. Journal of Pathology. 186:1998;75-81.
15. Tak P P, Thurkow E W, Daha M R. Expression of adhesion molecules in early rheumatoid synovial tissue. Clinical Immunology and Imunopathology. 77:1995;236-242.
16. Youssef P P, Cormack J, Evill C A. Neutrophil trafficking into inflamed joints in patients with rheumatoid arthritis and the effect of methylprednisolone. Arthritis and Rheumatism. 39:1996;216-225.
17. Smeets T JM, Dolhain R JEM, Miltenburg A MM. Poor expression of T cell-revived cytokines and activation of proliferation markers in early rheumatoid synovial tissue. Clinical Immunology and Immunopathology. 88:1998;84-90.
18. Kraan M C, Versendaal H, Jonker M. Asymptomatic synovitis precedes clinically manifest arthritis. Arthritis and Rheumatism. 41:1998;1481-1488.
19. Van der Heijden I M, Wilbrink B, Tchetverikov I. The presence of bacterial DNA and bacterial peptidoglycans in the joints of patients with rheumatoid arthritis and other arthritides. Arthritis and Rheumatism. 41:1998;S162.
20. FitzGerald O, Bresnihan B. Synovial membrane cellularity and vascularity. Annals of the Rheumatic Diseases. 54:1995;511-515.
21. Cruikshank B. Interpretation of multiple biopsies of synovial tissue in rheumatic diseases. Annals of the Rheumatic Diseases. 11:1952;137-145.
22. Kulka J P, Bocking D, Ropes M W, Bauer W. Early joint lesions of rheumatoid arthritis. Archives of Pathology. 59:1955;129-150.
23. Jayson M IV, Dixon A SJ. Arthroscopy of the knee in rheumatoid diseases. Annals of the Rheumatic Diseases. 27:1968;503-511.
24. Yates D B, Scott J T. Rheumatoid synovitis and joint disease: relationship between arthroscopic and histologic changes. Annals of the Rheumatic Diseases. 34:1975;1-6.
25. Henderson D RF, Jayson M IV, Tribe C R. Lack of correlation of synovial histology with joint damage in rheumatoid arthritis. Annals of the Rheumatic Diseases. 34:1975;7-11.
26. Lindblad S, Hedfors E. Intraarticular variation in synovitis. Local macroscopic and microscopic signs of inflammatory activity are significantly correlated. Arthritis and Rheumatism. 28:1985;977-986.
27. Hutton C W, Hinton C, Dieppe P. Intra-articular variation of synovial changes in knee arthritis: biopsy study comparing changes in patellofemoral synovium and the medial tibiofemoral synovium. British Journal of Rheumatology. 26:1987;5-8.
28. Rooney M, Condell D, Quinlan W. Analysis of the histologic variation of synovitis in rheumatoid arthritis. Arthritis and Rheumatism. 31:1988;956-963.
29. Bresnihan B, Cunnane G, Youssef P. Microsocpic measurement of synovial membrane inflammation in rheumatoid arthritis: proposals for the evaluation of tissue samples by quantitative analysis. British Journal of Rheumatology. 37:1998;636-642.
30. Dolhain R JEM, Terhaar N T, Dekuiper R. Distribution of T cells and signs of T cells activation in the rheumatoid joint: Implications for semiquantitative comparative histology. British Journal of Rheumatology. 37:1998;324-330.
31. Harris ED Jr. Pathogenesis of rheumatoid arthritis. Kelly W N, Harris E D Jr, Ruddy S, Sledge C B. Textbook of Rheumatology. 1984;14-23 WB Saunders Company, Philadelphia.
32. Youssef P P, Kraan M, Breedveld F. Quantitative microscopic analysis of inflammation in rheumatoid arthritis synovial membrane samples selected at arthroscopy compared with samples obtained blindly by needle biopsy. Arthritis and Rheumatism. 41:1998;663-669.
33. Goldenberg D L, Cohen A S. Synovial membrane histopathology in the differential diagnosis of rheumatoid arthritis, gout, pseudogout, systemic lupus erythematosus, infectious arthritis and degenerative joint disease. Medicine. 57:1978;239-252.
34. Koch A E, Robinson P G, Radosevich J A, Pope R M. Distribution of CD45RA and CD45RO T lymphocyte subsets in rheumatoid arthritis synovial tissue. Journal of Clinical Immunology. 10:1990;192-199.
35. Kahle P, Saal J G, Schaudt K. Determination of cytokines in synovial fluids: correlation with diagnosis and hisotmorphological characteristics of synovial tissue. Annals of the Rheumatic Diseases. 51:1992;731-734.
36. Yanni G, Whelan A, Feighery C, Bresnihan B. Synovial tissue macrophages and joint erosion in rheumatoid arthritis. Annals of the Rheumatic Diseases. 53:1994;39-44.
37. Tak P P, van der Lubbe P A, Cauli A. Reduction of synovial inflammation after anti-CD4 monoclonal antibody treatment in early rheumatoid arthritis. Arthritis and Rheumatism. 38:1995;1457-1465.
38. Tak P P, Taylor P C, Breedveld F C. Decrease in cellularity and expression of adhesion molecules by anti-tumor necrosis factor α monoclonal antibody treatment in patients with rheumatoid arthritis. Arthritis and Rheumatism. 39:1996;1077-1081.
39. Mulherin D, Fitzgerald O, Bresnihan B. Synovial tissue macrophage populations and articular damage in rheumatoid arthritis. Arthritis and Rheumatism. 39:1996;115-124.
40. Youssef P, Smeets T JMM, Bresnihan B. Microscopic measurement of cellular infiltration in the rheumatoid arthritis synovial membrane: a comparison of semiquantitative and quantitative analysis. British Journal of Rheumatology. 37:1998;1003-1007.
41. Cunnane, G, Bjork, L, Ulfgren, A-K, Quantitative analysis of synovial membrane inflammation: a comparison between automated and conventional microscopic measurement, Annals of the Rheumatic Diseases.
42. Kraan, M, Haringman, J, J, Ahern, M, J, Digital image analysis for the quantification of the cell infiltrate in synovial tissue. (Submitted).
43. Tak P P, Breedveld F C. Analysis of serial synovial biopsies as a screening method for predicting the effects of therapeutic interventions. Journal of Clinical Rheumatology. 3:1997;186-187.
44. Rooney M, Whelan A, Feighery C, Bresnihan B. Changes in lymphocyte infiltration of the synovial membrane and the clinical course of rheumatoid arthritis. Arthritis and Rheumatism. 32:1989;361-369.
45. De Bois M HW, Tak P P, Arndt J W. Joint scintigraphy for quantification of synovitis with 99 m Tc-labelled human immunoglobulin G compared to histological examination. Clinical Experimental Rheumatology. 13:1995;155-159.
46. Rooney M, Whelan A, Feighery C, Bresnihan B. The immunohistologic features of synovitis, disease activity and in-vitro IgM rheumatoid factor synthesis by blood mononuclear cells in rheumatoid arthritis. Journal of Rheumatology. 16:1989;459-467.
47. Yanni G, Whelan A, Feighery C. Contrasting levels of in vitro cytokine production by rheumatoid synovial tissues demonstrating different patterns of mononuclear cell infiltration. Clinical Experimental Immunology. 93:1993;387-395.
48. Tak P P, Hintzen R Q, Teunissen J JM. Expression of the activation antigen CD27 in rheumatoid arthritis. Clinical Immunology and Immunopathology. 80:1996;129-138.
49. Namekawa T, Wagner U G, Goronzy J J, Weyand C M. Functional subsets of CD4 T cells in rheumatoid synovitis. Arthritis and Rheumatism. 41:1998;2108-2116.
50. FitzGerald O, Bresnihan B. Synovial membrane cellularity and vascularity. Annals of the Rheumatic Diseases. 54:1995;511-515.
51. Murphy E, Cassidy N, Youssef P. Marked down-regulation of E-selectin expression is associated with remission in rheumatoid arthritis. Arthritis and Rheumatism. 41:1998;S320.
52. Ruderman E M, Weinblatt M E, Thurmond LM, Pinkus G S, Gravellese E M. Synovial tissue response to treatment with Compath-1H. Arthritis and Rheumatism. 35:1995;254-258.
53. Walters M T, Smith J L, Moore K. An investigation of the action of disease modifying anti-rheumatoid drugs on the rheumatic synovial membrane: reduction in T lymphocyte subpopulations and HLA-DP and DQ antigen expression after gold or pencillamine therapy. Annals of the Rheumatic Diseases. 30:1987;1-10.
54. Yanni G, Nabil M, Farahat M R. Intramuscular gold decreases cytokine expression and macrophage numbers in the rheumatoid synovial membrane. Annals of the Rheumatic Diseases. 53:1994;315-322.
55. Firestein G S, Paine M M, Littman B H. Gene expression (collagenase, tissue inhibitor of metalloproteinases, complement, and HLA-DR) in rheumatoid arthritis and osteoarthritis synovium. Quantitative analysis and effect of intraarticular corticosteroids. Arthritis and Rheumatism. 34:1991;1094-1105.
56. De Bois M HW, Arndt J W, Tak P P. 99Tcm-labelled polyclonal human immunoglobulin G scintigraphy before and after intra-articular knee injection of triamcinolone hexacetonide in patients with rheumatoid arthritis. Nuclear Medicine Communications. 14:1993;883-887.
57. Youssef P P, Haynes D R, Triantafillou S. Effects of pulse methylprednisolone on inflammatory mediators in peripheral blood, synovial fluid, and synovial membrane in rheumatoid arthritis. Arthritis and Rheumatism. 40:1997;1400-1408.
58. Firestein G S, Paine M M, Boyle D L. Mechanism of methotrexate action in rheumatoid arthritis. Selective decrease in synovial collagenase gene expression. Arthritis and Rheumatism. 37:1994;193-200.
59. Dolhain R JEM, Tak P P, Dijkmans B AC. Methotrexate treatment reduced inflammatory cell numbers, expression of monokines and of adhesion molecules in synovial tissue of patients with rheumatoid arthritis. British Journal of Rheumatology. 37:1998;502-508.
60. +cells in patients with rheumatoid arthritis. Journal of Autoimmunology. 10:1997;87-97.
61. Rep M H, van Oosten B W, Roos M T. Treatment with depleting CD4 monoclonal antibody results in a preferential loss of circulating naive T cells but does not effect IFN-gamma secreting TH1 cells in humans. Journal of Clinical Investigation. 99:1997;2225-2231.
62. Paleolog E M, Hunt M, Elliot M J. Deactivation of vascular endothelium by monoclonal anti-tumor necrosis factor alpha antibody in rheumatoid arthritis. Arthritis and Rheumatism. 39:1996;1082-1091.
63. Arend W P, Dayer J M. Inhibition of the production and effects of interleukin-1 and tumor necrosis factor α in rheumatoid arthritis. Arthritis and Rheumatism. 38:1995;151-160.
64. Dinarello C A, Wolff S M. The role of interleukin-1 in disease. New England Journal of Medicine. 328:1993;106-113.
65. van den Berg W B. Lessons for joint destruction from animal models. Current Opinion in Rheumatology. 7:1997;221-228.
66. Bresnihan B, Alvaro-Garcia J M, Cobby M. Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist. Arthritis and Rheumatism. 41:1999;2196-2204.
67. Cunnane G, Madigan A, FitzGerald O, Bresnihan B. Treatment with recombinant human interleukin-1 receptor antagonist may reduce synovial infiltration in rheumatoid arthritis. Arthritis and Rheumatism. 39:1996;S245.
68. Arnason B GW, Dayal A, Qu Z X. Mechanisms of action of interferon-beta in multiple sclerosis. Springer Seminar of Immunopathology. 18:1996;125-148.
69. Rep M HG, Hintzen R Q, Polman C H, van Lier R AW. Recombinant interferon beta blocks proliferation but enhances interleukin-10 secretion by activated human T-cells. Journal of Neuroimmunology. 67:1996;111-118.
70. Brod S A, Marshall G DJ, Henninger E M. Interferon-beta 1b treatment decreases tumor necrosis factor-alpha and increases interleukin-6 production in multiple sclerosis. Neurology. 46:1996;1633-1638.
71. Chabot S, Williams G, Yong V W. Microglial production of TNF-alpha is induced by activated T lymphocytes. Involvement of VLA-4 and inhibition by interferon beta-1b. Journal of Clinical Investigations. 100:1997;604-612.
72. Tak P P, 't Hart B A, Krann M C. The effects of interferon-beta treatment on arthritis. Rheumatology. 38:1999;362-369.
73. Smeets T JM, Kraan M C, Versendaal H. Synovial tissue response to interferon-beta treatment in rheumatoid arthritis patients. Arthritis and Rheumatism. 41:1998;S56.
74. Tanaka Y, Otsuka T, Hotokebuchi T. Effect of IL-10 on collagen-induced arthritis in mice. Inflammation Research. 45:1996;283-288.
75. Walmsley M, Katsikis P D, Abney E. Interleukin-10 inhibition of the progression of established collagen-induced arthritis. Arthritis and Rheumatism. 39:1996;495-503.
76. Smeets, T, JM, Kraan, M, C, Versendaal, H, Analysis of serial biopsies in rheumatoid arthritis patients: description of a control group without clinical improvement after treatment with recombinant human IL-10 or placebo, Journal of Rheumatology.
77. Young A, Corbett M, Winfield J. A prognostic index for erosive changes in the hands, feet and cervical spines in early rheumatoid arthritis. British Journal of Rheumatology. 17:1988;94-101.
78. van der Heijde D MFM, van Riel P LCM, van Leeuwen M A. Prognostic factors for radiographic damage - and physical disability in early rheumatoid arthritis: a prospective follow-up study of 147 patients. British Journal of Rheumatology. 31:1992;519-525.
79. Yanni G, Whelan A, Feighery C, Bresnihan B. Synovial tissue macrophages and joint erosion in rheumatoid arthritis. Annals of Reheumatic Diseases. 53:1994;39-44.
80. Cunnane G, FitzGerald O, Hummel K. Protease gene expression in synovial tissue and joint damage in early inflammatory arthritis. Arthritis and Rheumatism. 41:1998;S320.